<DOC>
	<DOCNO>NCT00015171</DOCNO>
	<brief_summary>The purpose study use buprenorphine/naloxone treatment opioid dependence .</brief_summary>
	<brief_title>Buprenorphine Naloxone Treatment Opiate Dependence - 1</brief_title>
	<detailed_description>The objective study determine safety efficacy buprenorphine/naloxone combination tablet opiate dependence treatment .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<criteria>DSMIV diagnosis current opiate dependence male nonpregnant , nonnursing female 1859 yrs age Any significant medical condition AST ALT level great 3x 's upper limit normal level Current Axis I diagnosis opiate , caffeine nicotine dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>January 1999</verification_date>
	<keyword>opioid dependence</keyword>
</DOC>